FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma

被引：9
|
作者：
Hodgson, Richard [2 ]
Huang, Yi-Tung [3 ]
Steinke, Karin [2 ]
Kumar, Aravind S. Ravi [1 ,3 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld 4029, Australia
[2] Royal Brisbane & Womens Hosp, Dept Med Imaging, Brisbane, Qld 4029, Australia
[3] Queensland PET Serv, Brisbane, Qld 4029, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2010年 / 35卷 / 06期
关键词：
prostate; non-Hodgkin lymphoma; PET/CT; F-18; FDG; prognosis; NON-HODGKINS-LYMPHOMA; CARCINOMA; THERAPY;
D O I：
10.1097/RLU.0b013e3181db4eb7
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 76-year-old man was incidentally diagnosed with prostate lymphoma following transurethral resection of the prostate for prostatism. Staging F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed markedly increased FDG uptake in the prostate, with no evidence of other disease. Following combination chemotherapy, restaging FDG-PET/CT demonstrated a complete metabolic response. The patient subsequently achieved prolonged remission on follow-up. Because of its rarity, FDG-PET in predicting outcome after therapy has not been validated for primary prostate lymphoma. This case highlights the potential of FDG-PET/CT in not only evaluation of disease extent but also prognostication of primary lymphoma of the prostate. Copyright © 2010 by Lippincott Williams & Wilkins.
引用
收藏
页码：418 / 420
页数：3
相关论文
共 50 条
  • [41] FDG-PET/CT for diagnosis of primary ovarian cancer
    Kitajima, Kazuhiro
    Suzuki, Kayo
    Senda, Michio
    Kita, Masato
    Nakamoto, Yuji
    Onishi, Yumiko
    Maeda, Tetsuo
    Yoshikawa, Takeshi
    Ohno, Yoshiharu
    Sugimura, Kazuro
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (07) : 549 - 553
  • [42] The role of FDG-PET scans in the evaluation of lymphoma in 2012
    Bodet-Milin, C.
    Eugene, T.
    Gastinne, T.
    Bailly, C.
    Le Gouill, S.
    Dupas, B.
    Kraeber-Bodere, F.
    JOURNAL DE RADIOLOGIE DIAGNOSTIQUE ET INTERVENTIONNELLE, 2013, 94 (02) : 164 - 174
  • [43] Evaluation of residual or recurrent malignant lymphoma by FDG-PET
    Sokler, M
    Dohmen, BM
    Bokemeyer, C
    Brugger, W
    Kopp, A
    Bares, R
    Kanz, L
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1189 - 1189
  • [44] FDG-PET and radiotherapy in lymphoma
    Ricardi U.
    Specht L.
    Versari A.
    Berthelsen A.K.
    Clinical and Translational Imaging, 2015, 3 (4) : 321 - 330
  • [45] Whole body FDG-PET/CT in restaging of lymphoma.
    Freudenberg, LS
    Antoch, G
    Mueller, SP
    Goerges, R
    Bockisch, A
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 84P
  • [46] FDG-PET in Hodgkin lymphoma
    Kobe, C.
    Dietlein, M.
    Mauz-Koerholz, C.
    Engert, A.
    Borchmann, P.
    Sabri, O.
    Schober, O.
    Schicha, H.
    Kluge, R.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (06): : 235 - 238
  • [47] Role of FDG-PET/CT in the Staging of Patients with Follicular Lymphoma
    Yuda, Sayako
    Maruyama, Dai
    Kurihara, Hiroaki
    Maeshima, Akiko Miyagi
    Toyoda, Kosuke
    Nobuhiko, Yamauchi
    Makita, Shin-ichi
    Fukuhara, Suguru
    Munakata, Wataru
    Kobayashi, Yukio
    Taniguchi, Hirokazu
    Tobinai, Kensei
    BLOOD, 2015, 126 (23)
  • [48] Role of FDG-PET/CT in the management of pediatric Burkitt lymphoma
    Elhussein, Ahmed
    Rahman, Hany
    Fawzy, Mohamed
    Omar, Walid
    Hussein, Hany
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 68 - 69
  • [49] PROGNOSTICATION BY FDG-PET DETECTED BONE MARROW INVOLVEMENT IN HODGKINS LYMPHOMA - A RETROSPECTIVE ANALYSIS
    Menon, H.
    Chauhan, B.
    Rangarajan, V.
    Sengar, M.
    Dangi, U.
    Jain, H.
    HAEMATOLOGICA, 2014, 99 : 399 - 399
  • [50] Bone involvement in patients with lymphoma: the role of FDG-PET/CT
    Schaefer, Niklaus G.
    Strobel, Klaus
    Taverna, Christian
    Hany, Thomas F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (01) : 60 - 67
12345